Clinical significance of Ki-67 in patients with lung adenocarcinoma in situ complicated by type 2 diabetes

Table 3 Logistic regression analysis of factors influencing the risk of adenocarcinoma in situ and type 2 diabetes mellitus

Independent variables	β	Standard error	Wald	OR (95%CI)	P value
Ki-67	−0.140	0.045	9.697	0.870 (0.796–0.950)	0.002
FPG	0.654	0.234	7.810	1.923 (1.216–3.043)	0.005
HbA1c	1.452	0.690	15.036	11.563 (2.165-12.016)	< 0.01
Insulin	−0.126	0.057	4.880	0.882 (0.788–0.986)	0.027
HDL-C	−3.151	1.151	7.495	0.043 (0.004–0.409)	0.006
TC	1.137	0.515	4.864	3.116 (1.135–8.556)	0.027
TG	0.054	0.405	0.018	1.056 (0.477–2.336)	0.893
LDL-C	0.377	0.381	0.978	1.458 (0.691–3.077)	0.323

FPG: Fasting plasma glucose; HbA₁c: Glycosylated hemoglobin; HDL-C: High-density lipoprotein cholesterol; TC: Total cholesterol; TG: Total triglyceride; LDL-C: Low-density lipoprotein cholesterol.